Welcome
Support Centre
29 August 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Which is better: Paravertebral (PV) or interplueral (IP) bupivacaine for breast surgery?
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN13771057
Date ISRCTN assigned12/09/2003
Local reference number(s)N0072091240
Public titleWhich is better: Paravertebral (PV) or interplueral (IP) bupivacaine for breast surgery?
Scientific title
AcronymN/A
Disease/condition/study domainSurgery: Breast
Study hypothesisWhich is better: Paravertebral (PV) or interplueral (IP) bupivacaine for breast surgery?
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaAll patients having major breast surgery. Proposed 40 patients - 20 in each group.
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/04/2001
Anticipated end date01/07/2003
Status of trialCompleted
Target number of participants40
InterventionsRandomisation to two groups, standardised general anaesthetic, IP or PV block, recovery, test for failure, observed for pain, nausea and vomiting (N&V), patient-controlled analgesia (PCA) morphine consumption.
Primary outcome measure(s)1. Visual Analogue Pain Scores at rest and on movement
2. Nausea scale and vomiting episodes
3. Morphine and other analgesic consumption
4. Time to morphine demand
5. Hospital stay
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingCountess of Chester Hospital NHS Trust
Sponsor nameRecord provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Sponsor detailsThe Department of Health
Richmond House
79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor fax+44 (0)20 7307 2623
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.doh.gov.uk
Contact nameDr Sean Tighe
Contact detailsCountess of Chester NHS Trust
Liverpool Road


Chester, Cheshire
United Kingdom
CH3 1UL
Contact telephone+44 01244 365000
Contact fax+44
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN13771057
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central